Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries

Back

ESC Professional Premium Access

Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries

Session: Pharmacotherapy of acute coronary syndromes in clinical practice

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Speaker: Doctor A. Sigal (Buenos Aires, AR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Alan Rodrigo Sigal

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

0 follower

6 more presentations in this session

Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry

Speaker: Doctor E. Ravetti (Turin, IT)

Changes of hospital-level variation in use of optimal medical treatment for long-term follow-up from a multi-level methodological approach

Speaker: Doctor H. Kwak (Daegu, KR)

Access

Abstract

Slides

Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

Speaker: Professor L. Rallidis (Athens, GR)

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

Speaker: Professor R. Marcucci (Florence, IT)

One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk

Speaker: Doctor C. Pivato (Milan, IT)

Access the full session

Pharmacotherapy of acute coronary syndromes in clinical practice

Speakers: Doctor A. Sigal, Doctor E. Ravetti, Doctor H. Kwak, Professor L. Rallidis, Professor R. Marcucci...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries

About the speaker

Doctor Alan Rodrigo Sigal

6 more presentations in this session

Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry

Changes of hospital-level variation in use of optimal medical treatment for long-term follow-up from a multi-level methodological approach

Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk

Access the full session

Pharmacotherapy of acute coronary syndromes in clinical practice

About the event

ESC Congress 2023

ESC 365 is supported by